 |
|
|
| |
Correlation of Early Biochemical and Virologic Responses During
Oral Antiviral Therapy for Chronic Hepatitis B
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Maurizia R. Brunetto,1 Sang Hoon Ahn,2 Ting-Tsung Chang,3 Seng-Gee Lim,4 Adrian Streinu-Cercel,5 John F. Flaherty,6 Kyungpil Kim,6 Robert P. Myers,6 Anuj Gaggar,6 G Mani Subramanian,6 Wendy Cheng,7 Magdy Elkhashab,8 Namiki Izumi9
1Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; 2Yonsei University College of Medicine, Seoul, Korea; 3National Cheng Kung University Hospital, Tainan, Taiwan; 4National University Hospital, Singapore; 5Institutul National de Boli Infectioase "Prof. Dr. Matei Bals," Bucharest, Romania;
6Gilead Sciences, Inc., Foster City, CA; 7Royal Perth Hospital, Perth, Western Australia, Australia; 8Toronto Liver Centre, Toronto, Ontario, Canada; 9Japanese Red Cross Musashino Hospital, Tokyo, Japan
References
1. Babusis D, et al. Mol Pharm 2013;10:459-66; 2. Lee WA, et al. Antimicrob Agents Chemother 2005;49:1898-906; 3. Murakami E, et al. Antimicrob Agents Chemother 2015;59:3563-9; 4. Agarwal K, et al. J Hepatol 2015;62:533-40; 5. Sax P, et al. Lancet 2015;385:2606-15; 6. European Association for the Study of the Liver. J Hepatol 2012;57:167-85; 7. Terrault NA, et al. Hepatology 2016;63:261-83.
|
| |
|
|
|
|
|
